BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 15314234)

  • 1. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].
    Emami KH; Nguyen C; Ma H; Kim DH; Jeong KW; Eguchi M; Moon RT; Teo JL; Kim HY; Moon SH; Ha JR; Kahn M
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12682-7. PubMed ID: 15314234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.
    Ma H; Nguyen C; Lee KS; Kahn M
    Oncogene; 2005 May; 24(22):3619-31. PubMed ID: 15782138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.
    Shtutman M; Zhurinsky J; Simcha I; Albanese C; D'Amico M; Pestell R; Ben-Ze'ev A
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5522-7. PubMed ID: 10318916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
    Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
    Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone.
    Natsume H; Sasaki S; Kitagawa M; Kashiwabara Y; Matsushita A; Nakano K; Nishiyama K; Nagayama K; Misawa H; Masuda H; Nakamura H
    Biochem Biophys Res Commun; 2003 Sep; 309(2):408-13. PubMed ID: 12951064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway.
    Grueneberg DA; Pablo L; Hu KQ; August P; Weng Z; Papkoff J
    Mol Cell Biol; 2003 Jun; 23(11):3936-50. PubMed ID: 12748295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma activation modulates cyclin D1 transcription via beta-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes.
    Sharma C; Pradeep A; Pestell RG; Rana B
    J Biol Chem; 2004 Apr; 279(17):16927-38. PubMed ID: 14764597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 down-regulation.
    Li H; Liu L; David ML; Whitehead CM; Chen M; Fetter JR; Sperl GJ; Pamukcu R; Thompson WJ
    Biochem Pharmacol; 2002 Nov; 64(9):1325-36. PubMed ID: 12392815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.
    Henderson BR; Galea M; Schuechner S; Leung L
    J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.
    Eguchi M; Nguyen C; Lee SC; Kahn M
    Med Chem; 2005 Sep; 1(5):467-72. PubMed ID: 16787331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activity.
    Guo RJ; Huang E; Ezaki T; Patel N; Sinclair K; Wu J; Klein P; Suh ER; Lynch JP
    J Biol Chem; 2004 Aug; 279(35):36865-75. PubMed ID: 15215241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
    Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.
    Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
    Chen RH; McCormick F
    Cancer Res; 2001 Jun; 61(11):4445-9. PubMed ID: 11389074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
    Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
    Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells.
    Pradeep A; Sharma C; Sathyanarayana P; Albanese C; Fleming JV; Wang TC; Wolfe MM; Baker KM; Pestell RG; Rana B
    Oncogene; 2004 Apr; 23(20):3689-99. PubMed ID: 15116100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway.
    Sharma C; Pradeep A; Wong L; Rana A; Rana B
    J Biol Chem; 2004 Aug; 279(34):35583-94. PubMed ID: 15190077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma.
    Rockman SP; Currie SA; Ciavarella M; Vincan E; Dow C; Thomas RJ; Phillips WA
    J Biol Chem; 2001 Nov; 276(48):45113-9. PubMed ID: 11572874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.